1. Home
  2. YJ vs CERO Comparison

YJ vs CERO Comparison

Compare YJ & CERO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • YJ
  • CERO
  • Stock Information
  • Founded
  • YJ 2015
  • CERO 2017
  • Country
  • YJ China
  • CERO United States
  • Employees
  • YJ N/A
  • CERO N/A
  • Industry
  • YJ Other Specialty Stores
  • CERO
  • Sector
  • YJ Consumer Discretionary
  • CERO
  • Exchange
  • YJ Nasdaq
  • CERO Nasdaq
  • Market Cap
  • YJ 8.8M
  • CERO 8.4M
  • IPO Year
  • YJ 2019
  • CERO N/A
  • Fundamental
  • Price
  • YJ $1.84
  • CERO $1.92
  • Analyst Decision
  • YJ
  • CERO
  • Analyst Count
  • YJ 0
  • CERO 0
  • Target Price
  • YJ N/A
  • CERO N/A
  • AVG Volume (30 Days)
  • YJ 48.1K
  • CERO 827.7K
  • Earning Date
  • YJ 03-20-2025
  • CERO 02-20-2025
  • Dividend Yield
  • YJ N/A
  • CERO N/A
  • EPS Growth
  • YJ N/A
  • CERO N/A
  • EPS
  • YJ N/A
  • CERO N/A
  • Revenue
  • YJ $66,957,730.00
  • CERO N/A
  • Revenue This Year
  • YJ N/A
  • CERO N/A
  • Revenue Next Year
  • YJ N/A
  • CERO N/A
  • P/E Ratio
  • YJ N/A
  • CERO N/A
  • Revenue Growth
  • YJ N/A
  • CERO N/A
  • 52 Week Low
  • YJ $1.42
  • CERO $1.76
  • 52 Week High
  • YJ $4.72
  • CERO $1,238.00
  • Technical
  • Relative Strength Index (RSI)
  • YJ 53.54
  • CERO 34.43
  • Support Level
  • YJ $1.68
  • CERO $1.76
  • Resistance Level
  • YJ $1.93
  • CERO $3.18
  • Average True Range (ATR)
  • YJ 0.13
  • CERO 0.38
  • MACD
  • YJ 0.02
  • CERO 0.30
  • Stochastic Oscillator
  • YJ 69.70
  • CERO 19.72

About YJ Yunji Inc. American Depository Shares

Yunji Inc is a social e-commerce platform in China that offers a membership-based model that leverages the power of social interaction. The company provides a host of selected commodities such as beauty and personal care, mobile phones and digital products, baby and maternal products, toys, fruits, and other fresh products. It has expanded to operate its business, including the marketplace, on a diverse range of sales channels and other platforms. Geographically, the firm operates in China.

About CERO CERo Therapeutics Holdings Inc. Common Stock

CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T-cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy.

Share on Social Networks: